Advancing discovery from lab to life through AI-driven insights, imaging, and end-to-end workflows WALTHAM, Mass. — Revvity, Inc. is showcasing its latest innovations in cancer research at the AACR Annual Meeting 2026, to be held in San Diego, April 17-22. The Company’s comprehensive suite of research use only (RUO) oncology solutions are designed to elevate preclinical and translational […]
Bio-Techne introduces a streamlined brand architecture that organizes its technologies into three focused portfolio brands: R&D Systems™, Bio-Techne Spatial™, and Bio-Techne Diagnostics™. The new brand structure reflects the scientific journey, connecting early discoveries to translational insight to clinical decision-making. The portfolio brands will debut at the AACR Annual Meeting 2026 and AAI’s IMMUNOLOGY 2026™. MINNEAPOLIS — […]
Fremont, Calif. – Alamar Biosciences, Inc. (“Alamar”), a leader in precision proteomics dedicated to advancing the early detection of disease, today announced the pricing of its upsized initial public offering of 11,250,000 shares of its common stock at a public offering price of $17.00 per share. In addition, Alamar has granted the underwriters a 30-day option […]
Awards celebrate scientists making a difference through scientific mentorship, humanitarian service, environmental stewardship and artistic/creative spirit IPSWICH, MA – New England Biolabs (NEB®) today announced an invitation for scientists to submit entries for the 2026 Passion in Science Awards, recognizing those within the scientific community working to make a difference in the areas of scientific mentorship, humanitarian […]
The Content Innovation Engine brings together Akoya’s spatial biology platform and Quanterix’s immunoassay infrastructure to systematically unlock cancer biology and accelerate the path toward clinical application BILLERICA, Mass. — Quanterix Corporation (Nasdaq: QTRX) today announced plans to debut its Content Innovation Engine at the American Association for Cancer Research (AACR) Annual Meeting 2026. Built on the integration […]
Development of novel Ankyrons will enable study of emerging high-consequence infectious diseases to inform vaccines and treatments OXFORD, UK — ProImmune, Ltd., a global leader in immunological reagents and services, today announced a collaboration with The University of Texas Medical Branch (UTMB) Galveston National Laboratory (GNL), a high-containment, infectious disease research facility, to develop innovative tools […]
Expanded antibody portfolio enhances detection of biologics and YTE-modified therapeutics for bioanalytical applications Bio-Rad anti-idiotypic antibodies HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today extended its range of recombinant monoclonal anti-idiotypic antibodies, with the introduction of eight antibodies specific to romosuzumab […]
CAMBRIDGE, England — Abcam, a Danaher company and a global provider of validated antibodies and assay solutions, today announced SimpleStep Ignite™ ELISA, a next generation chemiluminescent immunoassay platform designed for scientists who need faster and higher quality decisions without compromising data integrity. Delivering results in 55 minutes – up to 6× faster than traditional colorimetric ELISAs, SimpleStep Ignite™ combines 50× greater sensitivity with an up to 35× […]
WALTHAM, Mass. — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a strategic collaboration with Precision Health Research, Singapore (PRECISE) to advance the PRECISE-SG100K study, one of the region’s most ambitious and diverse population-scale biobank initiatives. The collaboration reflects growing investments from national population studies looking to harness proteomics […]
CTL adds analyzers, software, consumables, and services at a workflow-critical measurement layer across translational and clinical research SHAKER HEIGHTS, Ohio — VION Biosciences (“VION”), a life sciences company building differentiated capabilities across research, diagnostics, and drug development workflows, today announced the closing of its acquisition of Cellular Technology Limited (“CTL”), a provider of functional immune […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
